Development of CRISPR/Cas system for study of trans-sialidase family genes in T. cruzi
Development of CRISPR/Cas system for study of trans-sialidase family genes in T. cruzi
批准号:
9054467
负责人:
Rick L Tarleton
金额:
$18.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-01-15 至 2017-12-31
关键词:
AddressAffectAmericasAnimalsArchitectureAreaBiologicalBiologyBurn injuryCRISPR/Cas technologyCell NucleusCellsChagas DiseaseCharacteristicsClustered Regularly Interspaced Short Palindromic RepeatsCommunicable DiseasesCommunitiesComplexDevelopmentDiagnosticEpitopesFamilyFamily memberFrequenciesGene ExpressionGene FamilyGenesGeneticGenetic RecombinationGenetic ScreeningGenomeGrowthGuide RNAHandHumanImmuneImmune responseImmunityInfectionInsectaInvestigationKnock-outLengthLightMediatingModificationMucinsMusMutateMutationOrganismParasitesPathogenicityPathologyPlaguePositioning AttributeProteinsResearchRoleSurfaceSystemTechnologyTestingTranscription Repressor/CorepressorTrypanosoma cruziTrypanosoma cruzi trans-sialidaseVaccinesVariantVisionWorkempoweredgene functiongenetic analysisgenetic manipulationgenome editinggenome-widehigh rewardhigh riskhomologous recombinationimprovedknockout genemembermutantnovelnucleaseparasite genomepathogenprediction algorithmpublic health relevancerepairedresearch studytooltrans-sialidase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The complexity and unique characteristics of the Trypanosoma cruzi genome and the relative paucity of tools to manipulate that genome are some of the challenges in the study of parasite persistence and pathogenicity that results in Chagas disease. As the highest impact infectious disease of the Americas with up to 20 million humans and innumerable animals affected, T. cruzi is plagued by poor diagnostic tools, inadequate treatment options and no effective vaccines. New discoveries in all these areas would be greatly facilitated by improved genome editing tools for T. cruzi. We have recently applied CRISPR technology to T. cruzi and demonstrate dramatically increased gene knockout and gene insertion efficiency, providing an unparalleled opportunity for genetic analysis in this important human pathogen. In this project we will further enhance the CRISPR-Cas system in T. cruzi by improving the ability to regulate Cas9 expression, better defining the mechanisms of DNA recombination used to repair Cas9-mediated double-stranded breaks, and using this information to optimize homologous recombination in T. cruzi. Using the demonstrated multiplexing capabilities of CRISPR-Cas9, we will then assess the ability to mutate of large numbers of genes encoding trans-sialidase (ts) molecules in order to evaluate the hypothesis that the ts family of molecules serves an immune evasion function for T. cruzi. This proposal combines the novel use and further development of a powerful genetic system that we demonstrate to be highly efficient in T. cruzi, with an important biological question that up to no was not experimentally tractable. Understanding the role of large gene families in the persistence and pathology of T. cruzi is only possible if we can reduce the number of family members and observe the consequences. Completion of this work is also expected to firmly establish the CRISPR-Cas system as an indispensable tool for the study of T. cruzi.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The activation of benzoxaborole prodrug AN15368, a clinical candidate for Chagas disease
-
批准号:10667721
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2023
-
负责人:Rick L Tarleton
-
依托单位:
Optimizing blood PCR as test of cure in Chagas disease
-
批准号:10451977
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2022
-
负责人:Rick L Tarleton
-
依托单位:
Optimizing blood PCR as test of cure in Chagas disease
-
批准号:10590740
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2022
-
负责人:Rick L Tarleton
-
依托单位:
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
-
批准号:10573204
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2020
-
负责人:Rick L Tarleton
-
依托单位:
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
-
批准号:10368984
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2020
-
负责人:Rick L Tarleton
-
依托单位:
Purchase of an imaging flow cytometer 2016
-
批准号:9273704
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2017
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9754759
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Multiplex treatment outcomes test for Chagas disease
-
批准号:9305839
-
项目类别:
-
资助金额:$100.08万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9237877
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9979735
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Generation of reference genomes for Trypanosoma cruzi using PacBio sequencing
-
批准号:9251753
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Making benznidazole a better drug for Chagas disease
-
批准号:8652132
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2014
-
负责人:Rick L Tarleton
-
依托单位:
Making benznidazole a better drug for Chagas disease
-
批准号:8903699
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8968183
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8585810
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8390470
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8237761
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Multi-color Flow Analyzer for the UGA-CTEGD Flow Facility
-
批准号:7794363
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2010
-
负责人:Rick L Tarleton
-
依托单位:
Multiplex serodiagnostic test for Chagas disease
-
批准号:8103493
-
项目类别:
-
资助金额:$78.25万
-
财政年份:2010
-
负责人:Rick L Tarleton
-
依托单位:
Drug Discovery Consortium for Chagas Disease
-
批准号:7656093
-
项目类别:
-
资助金额:$113.77万
-
财政年份:2009
-
负责人:Rick L Tarleton
-
依托单位:
海外基金